• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

FDA extends Class I UDI submission deadline, exempts consumer health devices from requirements

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 02, 2022 at 11:12: AM
via The Food and Drug Administration has given manufacturers of certain Class I and unclassified devices another 75 calendar days to comply with Global Unique Device Identification Database (GUDID) submission requirements.

article source
 




Top Bottom
Back
Quote